Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study

PLoS One. 2014 Apr 10;9(4):e94485. doi: 10.1371/journal.pone.0094485. eCollection 2014.

Abstract

In this study, the clinical and immunogenetical features in a cohort of Chinese patients with BCGosis/BCGitis were investigated. For the patients with abnormal immunological functions, Sanger sequencing was used to identify the involved genes. There were 74 confirmed cases of BCGosis/BCGitis during 2007-2012. Classified by infected tissues and organs, no cases only had local infection, 39 patients had a regional infection, 21 patients had a distant infection and 14 patients had a disseminated infection. Thirty-two patients (43.2%) had definitive primary immunodeficiency diseases (PID) and chronic granulomatous disease (CGD) is the most common PID (n = 23, accounted for 71.9% of all PID patients). For CGD patients, based on the anti-tuberculosis treatment, administration of rhIFN-γ resulted in better control of BCGosis/BCGitis. The results indicate that PIDs are associated with susceptibility to BCG disease. For children with BCGosis/BCGitis, immune function evaluation is necessary, and IFN-γ treatment for BCGosis/BCGitis patients with CGD is effective.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BCG Vaccine / administration & dosage
  • BCG Vaccine / adverse effects*
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Immunogenetics
  • Immunoglobulins / blood
  • Immunologic Deficiency Syndromes / immunology*
  • Immunologic Deficiency Syndromes / physiopathology
  • Infant
  • Infant, Newborn
  • Interferon-gamma / therapeutic use
  • Lymphocyte Subsets / immunology
  • Male
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium Infections, Nontuberculous / etiology
  • Mycobacterium Infections, Nontuberculous / immunology*
  • Mycobacterium Infections, Nontuberculous / physiopathology
  • Severity of Illness Index
  • Tuberculosis / prevention & control

Substances

  • BCG Vaccine
  • Immunoglobulins
  • Interferon-gamma

Supplementary concepts

  • BCG Infection, Generalized Familial

Grants and funding

This work was supported by National Natural Science Foundation of China (81172877) and Shanghai Rising-Star Program (11QA1400700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.